Viveve Medical (NASDAQ:VIVE – Get Free Report) is projected to post its resultson Friday, March 20th. Analysts expect Viveve Medical to post earnings of $0.01 per share and revenue of $12.00 million for the quarter.
Viveve Medical Stock Performance
NASDAQ:VIVE opened at $0.00 on Friday. Viveve Medical has a twelve month low of $0.00 and a twelve month high of $0.02.
Viveve Medical Company Profile
Viveve Medical, Inc is a medical technology company focused on the development and commercialization of non-invasive solutions for women’s intimate health. The company’s flagship offering, the Viveve System, employs proprietary cryogen-cooled monopolar radiofrequency energy to gently heat and remodel vaginal tissue. This technology is designed to address conditions such as vaginal laxity and associated symptoms, offering a single-treatment protocol that can be performed in a clinical setting without the need for anesthesia.
Regulatory clearances, including U.S.
Featured Stories
- Five stocks we like better than Viveve Medical
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.
